Board member
Leif Rune Skymoen is the General Manager of Legemiddelindustrien (LMI), The association for the pharmaceutical industry in Norway. He has previously been Country Director for Eli Lilly in Norway and CEO of Nansen Neuroscience Cluster. Skymoen was also co-founder of the Norwegian contract development and manufacturing company Curida, in which he served as CEO for more than eight years.
He earned his Master’s degree in pharmacy at the University of Oslo and the University of Oxford, and also holds an Executive Master of Management degree from The Norwegian Business School.
Skymoen has served on the board of several companies and organizations.